α2β1 Integrin Ligand Peptide (TFA)

α2β1 Integrin Ligand Peptide (TFA)

• UNSPSC Description: α2β1 Integrin Ligand Peptide TFA interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors[1].
• Target Antigen: Integrin
• Type: Peptides
• Related Pathways: Cytoskeleton
• Applications: Neuroscience-Neuromodulation
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/alpha-2-beta-1-integrin-ligand-peptide-tfa.html
• Purity: 99.02
• Solubility: H2O : 33.33 mg/mL (ultrasonic)
• Smiles: C[C@H](NC([C@@H](NC(CNC([C@@H](N)CC(O)=O)=O)=O)CCC(O)=O)=O)C(O)=O.OC(C(F)(F)F)=O
• Molecular Weight: 504.37
• References & Citations: [1]Graham KL, et al. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol. 2004 Nov;78(21):11786-97.Acta Biomater. 2021 Mar 9;S1742-7061(21)00152-5.|Cancer Manag Res. 2020 Nov 24;12:12067-12075.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
• Clinical Information: No Development Reported